WO2007059007A3 - Markers of definitive endoderm - Google Patents

Markers of definitive endoderm Download PDF

Info

Publication number
WO2007059007A3
WO2007059007A3 PCT/US2006/043932 US2006043932W WO2007059007A3 WO 2007059007 A3 WO2007059007 A3 WO 2007059007A3 US 2006043932 W US2006043932 W US 2006043932W WO 2007059007 A3 WO2007059007 A3 WO 2007059007A3
Authority
WO
WIPO (PCT)
Prior art keywords
definitive endoderm
markers
disclosed
endoderm cells
enriching
Prior art date
Application number
PCT/US2006/043932
Other languages
French (fr)
Other versions
WO2007059007A2 (en
Inventor
Amour Kevin Allen D
Lan D Agulnick
Emmanuel Edward Baetge
Original Assignee
Cythera Inc
Amour Kevin Allen D
Lan D Agulnick
Emmanuel Edward Baetge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cythera Inc, Amour Kevin Allen D, Lan D Agulnick, Emmanuel Edward Baetge filed Critical Cythera Inc
Priority to US12/093,590 priority Critical patent/US8586357B2/en
Publication of WO2007059007A2 publication Critical patent/WO2007059007A2/en
Publication of WO2007059007A3 publication Critical patent/WO2007059007A3/en
Priority to US14/066,441 priority patent/US9605243B2/en
Priority to US15/427,876 priority patent/US20170216365A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0613—Cells from endocrine organs
    • C12N5/0617—Thyroid and parathyroid glands
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • C12N5/068—Stem cells; Progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled

Abstract

Disclosed herein are reagent-cell complexes comprising one or more definitive endoderm cells. Also described herein are compositions for detecting definitive endoderm. Method of enriching, isolating and/or purifying definitive endoderm cells are also disclosed.
PCT/US2006/043932 2003-12-23 2006-11-13 Markers of definitive endoderm WO2007059007A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/093,590 US8586357B2 (en) 2003-12-23 2006-11-13 Markers of definitive endoderm
US14/066,441 US9605243B2 (en) 2003-12-23 2013-10-29 Markers of definitive endoderm
US15/427,876 US20170216365A1 (en) 2003-12-23 2017-02-08 Markers of definitive endoderm

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73659805P 2005-11-14 2005-11-14
US60/736,598 2005-11-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/021,618 Continuation-In-Part US7510876B2 (en) 2003-12-23 2004-12-23 Definitive endoderm

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/093,590 A-371-Of-International US8586357B2 (en) 2003-12-23 2006-11-13 Markers of definitive endoderm
US14/066,441 Continuation US9605243B2 (en) 2003-12-23 2013-10-29 Markers of definitive endoderm

Publications (2)

Publication Number Publication Date
WO2007059007A2 WO2007059007A2 (en) 2007-05-24
WO2007059007A3 true WO2007059007A3 (en) 2007-08-30

Family

ID=37762579

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/043932 WO2007059007A2 (en) 2003-12-23 2006-11-13 Markers of definitive endoderm

Country Status (2)

Country Link
US (3) US8586357B2 (en)
WO (1) WO2007059007A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691217B2 (en) 2005-12-29 2014-04-08 Anthrogenesis Corporation Placental stem cell populations
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266554A1 (en) * 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
US7541185B2 (en) * 2003-12-23 2009-06-02 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
US8586357B2 (en) 2003-12-23 2013-11-19 Viacyte, Inc. Markers of definitive endoderm
CN103898047B (en) 2003-12-23 2020-03-03 维亚希特公司 Definitive endoderm
WO2007051038A2 (en) 2005-10-27 2007-05-03 Cythera, Inc. Pdx1-expressing dorsal and ventral foregut endoderm
DK2420565T3 (en) 2006-02-23 2017-12-04 Viacyte Inc APPLICABLE COMPOSITIONS AND METHODS FOR CULTIVATING DIFFERENTIBLE CELLS
DK1999253T3 (en) 2006-03-02 2019-08-12 Viacyte Inc ENDOCRINE PRECURSOR CELLS, PANCREATIC HORMON-EXPRESSING CELLS AND PROCEDURES FOR MANUFACTURING
US11254916B2 (en) 2006-03-02 2022-02-22 Viacyte, Inc. Methods of making and using PDX1-positive pancreatic endoderm cells
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
US8895300B2 (en) 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
US8008075B2 (en) * 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
EP2356227B1 (en) 2008-11-14 2018-03-28 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
WO2012115619A1 (en) 2011-02-21 2012-08-30 Viacyte, Inc. Loading system for an encapsulation device
US9040035B2 (en) 2011-06-01 2015-05-26 Anthrogenesis Corporation Treatment of pain using placental stem cells
CN102998441A (en) * 2012-11-20 2013-03-27 哈德逊（天津）生物技术有限责任公司 Kit for quickly detecting induced pluripotent stem cells
JP6514689B2 (en) 2013-06-11 2019-05-15 プレジデント アンド フェローズ オブ ハーバード カレッジ SC-β cells and compositions and methods for producing the same
US11051900B2 (en) 2014-04-16 2021-07-06 Viacyte, Inc. Tools and instruments for use with implantable encapsulation devices
SG10201801654RA (en) 2014-05-28 2018-04-27 Childrens Hospital Med Ct Methods and systems for converting precursor cells into gastric tissues through directed differentiation
JP6804438B2 (en) 2014-10-17 2020-12-23 チルドレンズ ホスピタル メディカル センター An in vivo model of the human small intestine using pluripotent stem cells, and methods for making and using it.
CN107614678B (en) 2014-12-18 2021-04-30 哈佛学院校长同事会 Method for producing stem cell-derived beta cells and method for using same
US10190096B2 (en) 2014-12-18 2019-01-29 President And Fellows Of Harvard College Methods for generating stem cell-derived β cells and uses thereof
WO2016100898A1 (en) 2014-12-18 2016-06-23 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof
US11066650B2 (en) 2016-05-05 2021-07-20 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
MA45502A (en) * 2016-06-21 2019-04-24 Janssen Biotech Inc GENERATION OF FUNCTIONAL BETA CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS WITH GLUCOSE-DEPENDENT MITOCHONDRIAL RESPIRATION AND TWO-PHASE INSULIN SECRETION RESPONSE
CA3045145A1 (en) 2016-12-05 2018-06-14 Children's Hospital Medical Center Colonic organoids and methods of making and using same
CN111565707A (en) 2017-06-14 2020-08-21 森玛治疗公司 Devices and methods for delivering therapeutics
US10391156B2 (en) 2017-07-12 2019-08-27 Viacyte, Inc. University donor cells and related methods
KR20200087201A (en) 2017-11-15 2020-07-20 셈마 테라퓨틱스, 인크. Islet cell production composition and method of use
CA3108275A1 (en) 2018-08-10 2020-02-13 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
US20200080107A1 (en) 2018-09-07 2020-03-12 Crispr Therapeutics Ag Universal donor cells
JP2022547053A (en) 2019-09-05 2022-11-10 クリスパー セラピューティクス アクチェンゲゼルシャフト universal donor cells
WO2021044379A1 (en) 2019-09-05 2021-03-11 Crispr Therapeutics Ag Universal donor cells
AU2021328501A1 (en) 2020-08-15 2023-04-13 Regeneron Pharmaceuticals, Inc. Treatment of obesity in subjects having variant nucleic acid molecules encoding calcitonin receptor (CALCR)
EP4271795A1 (en) 2020-12-31 2023-11-08 CRISPR Therapeutics AG Universal donor cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063971A2 (en) * 2003-12-23 2005-07-14 Cythera, Inc Definitive endoderm

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5869620A (en) 1986-09-02 1999-02-09 Enzon, Inc. Multivalent antigen-binding proteins
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US6165993A (en) 1992-03-23 2000-12-26 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US7153684B1 (en) 1992-10-08 2006-12-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US6015671A (en) 1995-06-07 2000-01-18 Indiana University Foundation Myocardial grafts and cellular compositions
US6090592A (en) 1994-08-03 2000-07-18 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid on supports
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
CA2247502A1 (en) 1996-02-28 1997-09-04 Vanderbilt University Compositions and methods of making embryonic stem cells
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
ES2309999T3 (en) 1996-10-28 2008-12-16 University Of Lausanne METHOD FOR OLIGOMERIZATION OF PEPTIDES.
JP2001508302A (en) 1997-01-10 2001-06-26 ライフ テクノロジーズ，インコーポレイテッド Embryonic stem cell serum replacement
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
US5866366A (en) 1997-07-01 1999-02-02 Smithkline Beecham Corporation gidB
ATE347911T1 (en) 1997-09-15 2007-01-15 Genetic Immunity Llc COMPOSITIONS FOR DELIVERY OF GENES TO ANTIGEN-PRESENTING CELLS OF THE SKIN
CA2307807C (en) 1997-10-23 2008-09-02 Andrea G. Bodnar Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6117986A (en) 1998-06-10 2000-09-12 Intergen Company, L.P. Pyrimidines linked to a quencher
US6921811B2 (en) 1998-09-22 2005-07-26 Biosurface Engineering Technologies, Inc. Bioactive coating composition and methods
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
DE19852800C1 (en) 1998-11-16 2000-04-13 Univ Albert Ludwigs Freiburg Production of antibodies to a polypeptide encoded by a known DNA sequence comprises binding of antibodies produced by DNA vaccination to immobilized recombinantly expressed polypeptide
US6872389B1 (en) 1999-07-08 2005-03-29 Rhode Island Hospital Liver stem cell
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US7256042B2 (en) 2000-04-27 2007-08-14 Geron Corporation Process for making hepatocytes from pluripotent stem cells
WO2002010347A2 (en) 2000-08-01 2002-02-07 Yissum Research Development Company Directed differentiation of embryonic cells
AU2002226075A1 (en) 2000-10-23 2002-05-06 University Of Kansas Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion
US20040121460A1 (en) 2001-01-24 2004-06-24 Lumelsky Nadya L Differentiation of stem cells to pancreatic endocrine cells
AU2002345691C1 (en) 2001-06-13 2008-07-24 Massachusetts Institute Of Technology In vivo bioreactors
EP1298201A1 (en) 2001-09-27 2003-04-02 Cardion AG Process for the production of cells exhibiting an islet-beta-cell-like state
GB2415432B (en) 2001-12-07 2006-09-06 Geron Corp Islet cells from human embryonic stem cells
US20030138949A1 (en) 2001-12-12 2003-07-24 Anil Bhushan Methods for the regeneration of pancreatic islets and expansion of pancreatic endocrine cells
JP2006513727A (en) 2002-05-17 2006-04-27 マウント シナイ スクール オブ メディスン オブ ニューヨーク ユニバーシティー Mesodermal and adult endoderm cell populations
US20060003446A1 (en) 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
EP1507848A4 (en) 2002-05-28 2005-11-23 Becton Dickinson Co Expansion and transdifferentiation of human acinar cells
CA2487858A1 (en) 2002-05-28 2003-12-04 Novocell, Inc. Methods, compositions, and growth and differentiation factors for insulin-producing cells
US20060040385A1 (en) 2002-12-05 2006-02-23 Technion Research & Development Foundation Ltd. Cultured human pancreatic islets, and uses thereof
AU2004211654B2 (en) 2003-02-07 2009-03-05 Wisconsin Alumni Research Foundation Directed genetic modifications of human stem cells
US20070154981A1 (en) 2003-02-14 2007-07-05 The Board Of Trustees Of The Leland Stanford Junior University Insulin-producing cells derived from stem cells
US20030224411A1 (en) 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
US20040229350A1 (en) 2003-05-12 2004-11-18 Nikolai Strelchenko Morula derived embryonic stem cells
KR20060010820A (en) 2003-05-20 2006-02-02 도꾸리쯔교세이호징 리가가쿠 겐큐소 Preparation of endodermal stem cells
WO2005017131A2 (en) 2003-08-14 2005-02-24 THE GOUVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT F HEALTH AND HUMAN SERVICES Methods for the differentiation of human stem cells
WO2005033294A2 (en) 2003-09-30 2005-04-14 Regents Of The University Of California Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage
US7541185B2 (en) 2003-12-23 2009-06-02 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
US7625753B2 (en) 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
US8586357B2 (en) 2003-12-23 2013-11-19 Viacyte, Inc. Markers of definitive endoderm
WO2005097980A2 (en) 2004-03-26 2005-10-20 Geron Corporation New protocols for making hepatocytes from embryonic stem cells
JP4491014B2 (en) 2004-04-01 2010-06-30 ウイスコンシン アラムニ リサーチ ファンデーション Differentiation of stem cells into endoderm and pancreatic lineages
DK1740612T3 (en) 2004-04-27 2019-10-07 Viacyte Inc PDX1 EXPRESSING ENDODERM
CN102925406B (en) 2004-07-09 2019-11-22 维亚希特公司 Method of the identification for the factor of differentiating definitive endoderm
DK1773986T3 (en) 2004-07-09 2019-04-08 Viacyte Inc PRE-PRIMATIVE STRIP AND MESENDODERM CELLS
EP1791952A4 (en) 2004-08-13 2008-06-11 Univ Georgia Res Found Compositions and methods for self-renewal and differentiation in human embryonic stem cells
CA2580798A1 (en) 2004-09-29 2006-04-06 Cellartis Ab Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs)
EP1859026A2 (en) 2005-01-31 2007-11-28 ES Cell International Pte Ltd. Directed differentiation of embryonic stem cells and uses thereof
WO2007002210A2 (en) 2005-06-20 2007-01-04 Bresagen, Inc. Embryonic stem cell culture compositions and methods of use thereof
GB0602063D0 (en) 2006-02-02 2006-03-15 Univ Manchester Cell Culture
AU2007277364B2 (en) 2006-07-26 2010-08-12 Viacyte, Inc. Methods of producing pancreatic hormones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063971A2 (en) * 2003-12-23 2005-07-14 Cythera, Inc Definitive endoderm

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE UniProt [online] 1 October 2000 (2000-10-01), "1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma) (1-acylglycerol-3-phosphate O-acyltransferase 3).", XP002423131, retrieved from EBI accession no. UNIPROT:Q9NRZ7 Database accession no. Q9NRZ7 *
KAWAJI HIDEYA ET AL: "Exploration of novel motifs derived from mouse cDNA sequences.", GENOME RESEARCH MAR 2002, vol. 12, no. 3, March 2002 (2002-03-01), pages 367 - 378, XP002423116, ISSN: 1088-9051 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691217B2 (en) 2005-12-29 2014-04-08 Anthrogenesis Corporation Placental stem cell populations
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules

Also Published As

Publication number Publication date
US20170216365A1 (en) 2017-08-03
US20090220959A1 (en) 2009-09-03
US8586357B2 (en) 2013-11-19
US9605243B2 (en) 2017-03-28
US20140134726A1 (en) 2014-05-15
WO2007059007A2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
WO2007059007A3 (en) Markers of definitive endoderm
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2005070090A3 (en) Regulatory t cells suppress autoimmunity
WO2005003320A3 (en) Neuronal differentiation of stem cells
WO2006015209A3 (en) Differentiation of stem cells
WO2006071960A3 (en) Compositions and methods of treating cell proliferation disorders
WO2004029219A3 (en) Cell-based rna interference and related methods and compositions
TW200621253A (en) 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2006128150A3 (en) Crystalline solid forms of tigecycline and methods of preparing same
EP1943348A4 (en) Compositions, methods, and kits for amplifying nucleic acids
WO2008103935A3 (en) Novel tobacco compositions and methods of making
WO2007098352A3 (en) Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
WO2008130372A8 (en) Production of sterols in oleaginous yeast and fungi
WO2005084645A8 (en) Embolic particles
WO2007127841A3 (en) Compositions and methods of preparation thereof
IL179919A0 (en) Neural stem cells, compositions containing the same and methods for promoting the division thereof
WO2007130697A3 (en) Anti-ephb4 antibodies and methods using same
WO2006002348A3 (en) Solid and crystalline ibandronic acid
WO2006034035A3 (en) Treatment of ischemia
WO2008051197A3 (en) Small-molecule botulinum toxin inhibitors
WO2006024640A3 (en) Triazolophthalazines
WO2009079412A3 (en) Reverse transcriptase inhibitors
WO2008027600A3 (en) Imatinib compositions
WO2006069719A3 (en) Lyophilization of virosomes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12093590

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 06837413

Country of ref document: EP

Kind code of ref document: A2